Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT

Journal of Hematology and Oncology

Volumn 8, Issue 1, 2015, Pages

  Zhang, Xiao Hui ^a   Wang, Qian Ming ^a   Zhang, Jia Min ^a   Feng, Fei Er ^a   Wang, Feng Rong ^a   Chen, Huan ^a   Zhang, Yuan Yuan ^a   Chen, Yu Hong ^a   Han, Wei ^a   Xu, Lan Ping ^a   Liu, Kai Yan ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSE; GALACTOSE; GLYCOPROTEIN IB ALPHA; MESSENGER RNA; NEURAMINIDASE 1; OSELTAMIVIR; PROTEIN 14 3 3; PROTEIN 14 3 3 ZETA; PROTEIN BAD; PROTEIN BCL 2; SIALIC ACID; SIALIDASE; UNCLASSIFIED DRUG; ADHESION RECEPTOR; SIALIC ACID DERIVATIVE; THROMBIN RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DESIALYLATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; GRAFT FAILURE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFECTION; MALE; MITOCHONDRION; PATHOGENESIS; PHAGOCYTOSIS; PROLONGED ISOLATED THROMBOCYTOPENIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SIALYLATION; SYSTEMIC INFECTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS REACTIVATION; WESTERN BLOTTING; ADVERSE EFFECTS; ALLOTRANSPLANTATION; BLOOD; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; TUMOR CELL LINE; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; BLOOD PLATELETS; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOBLOTTING; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEURAMINIDASE; PHAGOCYTOSIS; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALIC ACIDS; THROMBOCYTOPENIA; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84944706257     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-015-0216-3     Document Type: Article

References (77)

1. Zhang X, Fu H, Xu L, Liu D, Wang J, Liu K, et al. Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes. Biol Blood Marrow Transplant. 2011;17(2):274-80. doi:10.1016/j.bbmt.2010.09.007.
2. Yamazaki R, Kuwana M, Mori T, Okazaki Y, Kawakami Y, Ikeda Y, et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant. 2006;38(5):377-84. doi:10.1038/sj.bmt.1705444.
3. First LR, Smith BR, Lipton J, Nathan DG, Parkman R, Rappeport JM. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood. 1985;65(2):368-74.
4. Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R, et al. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7(3):154-62. doi:10.1053/bbmt.2001.v7.pm11302549.
5. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood. 1989;73(4):1054-8.
6. Poon LM, Di Stasi A, Popat U, Champlin RE, Ciurea SO. Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. Am J Blood Res. 2013;3(3):260-4.
7. Bolwell B, Pohlman B, Sobecks R, Andresen S, Brown S, Rybicki L, et al. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant. 2004;33(4):419-23. doi:10.1038/sj.bmt.1704330.
8. Kim DH, Sohn SK, Jeon SB, Baek JH, Kim JG, Lee NY, et al. Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GvHD. Bone Marrow Transplant. 2006;37(1):101-8. doi:10.1038/sj.bmt.1705203.
9. Kong Y, Hu Y, Zhang XH, Wang YZ, Mo XD, Zhang YY, et al. Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(8):1190-7. doi:10.1016/j.bbmt.2014.04.015.
10. Bielski M, Yomtovian R, Lazarus HM, Rosenthal N. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation. Bone Marrow Transplant. 1998;22(11):1071-6. doi:10.1038/sj.bmt.1701499.
11. Zhang XH, Wang GX, Zhu HH, Liu YR, Xu LP, Han W, et al. Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2015;94(10):1689-98. doi:10.1007/s00277-015-2436-6.
12. Gilli SC, de Souza MS, de Castro V, Fernandes LG, Saad ST. Platelet associated IgG may be related with thrombocytopenia in patients with myelodysplastic syndromes. Leuk Res. 2012;36(5):554-9. doi:10.1016/j.leukres.2011.10.003.
13. Rajantie J, Javela K, Joutsi-Korhonen L, Kekomaki R. Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation. Eur J Haematol. 2004;72(4):268-72. doi:10.1111/j.1600-0609.2004.00215.x.
14. Grozovsky R, Hoffmeister KM, Falet H. Novel clearance mechanisms of platelets. Curr Opin Hematol. 2010;17(6):585-9. doi:10.1097/MOH.0b013e32833e7561.
15. Li J, Callum JL, Lin Y, Zhou Y, Zhu G, Ni H. Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage. Haematologica. 2014;99(4):e61-3. doi:10.3324/haematol.2013.102897.
16. Barsam SJ, Psaila B, Forestier M, Page LK, Sloane PA, Geyer JT, et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011;117(21):5723-32. doi:10.1182/blood-2010-11-321398.
17. Li J, van der Wal DE, Zhu G, Xu M, Yougbare I, Ma L, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun. 2015;6:7737. doi:10.1038/ncomms8737.
18. Peng J, Ma SH, Liu J, Hou Y, Liu XM, Niu T, et al. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemostasis. 2014;12(4):497-504. doi:10.1111/jth.12524.
19. Zeng Q, Zhu L, Tao L, Bao J, Yang M, Simpson EK, et al. Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbalpha antibodies. Am J Hematol. 2012;87(2):206-8. doi:10.1002/ajh.22211.
20. Wal DEvd, Zhu G, Li J, Vadasz B, Issaka Y, Lang S et al. Desialylation: a novel platelet clearance mechanism and a potential new therapeutic target in anti-GPIb antibody mediated thrombocytopenia. 54th ASH Annual Meeting and Exposition. 2012;120:Abstract 265.
21. Rumjantseva V, Hoffmeister KM. Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci. 2010;42(1):63-70. doi:10.1016/j.transci.2009.10.008.
22. Hoffmeister KM, Josefsson EC, Isaac NA, Clausen H, Hartwig JH, Stossel TP. Glycosylation restores survival of chilled blood platelets. Science. 2003;301(5639):1531-4. doi:10.1126/science.1085322.
23. Sorensen AL, Clausen H, Wandall HH. Carbohydrate clearance receptors in transfusion medicine. Biochim Biophys Acta. 2012;1820(11):1797-808. doi:10.1016/j.bbagen.2012.07.008.
24. Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sorensen AL, Larson G, et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med. 2009;15(11):1273-80. doi:10.1038/nm.2030.
25. Varki A. Sialic acids in human health and disease. Trends Mol Med. 2008;14(8):351-60. doi:10.1016/j.molmed.2008.06.002.
26. Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol. 2009;19(5):507-14. doi:10.1016/j.sbi.2009.06.003.
27. Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci. 2012;1253:16-36. doi:10.1111/j.1749-6632.2012.06517.x.
28. Jansen AJ, Josefsson EC, Rumjantseva V, Liu QP, Falet H, Bergmeier W, et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIbalpha metalloproteinase-mediated cleavage in mice. Blood. 2012;119(5):1263-73. doi:10.1182/blood-2011-05-355628.
29. Sorensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, Wandall HH, et al. Role of sialic acid for platelet life span: exposure of betagalactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood. 2009;114(8):1645-54. doi:10.1182/blood-2009-01-199414.
30. Lai YR, Chen YH, Hu DM, Jiang M, Liu QF, Liu L, et al. Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG). J Hematol Oncol. 2014;7:59. doi:10.1186/s13045-014-0059-3.
31. Wang Y, Chang YJ, Xu LP, Liu KY, Liu DH, Zhang XH, et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood. 2014;124(6):843-50. doi:10.1182/blood-2014-03-563130.
32. Liu H, Zhai X, Song Z, Sun J, Xiao Y, Nie D, et al. Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study. J Hematol Oncol. 2013;6:15. doi:10.1186/1756-8722-6-15.
33. Kharfan-Dabaja MA, Hamadani M, Reljic T, Nishihori T, Bensinger W, Djulbegovic B, et al. Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. J Hematol Oncol. 2013;6:2. doi:10.1186/1756-8722-6-2.
34. Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W, et al. Long-term followup of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer. 2013;119(5):978-85. doi:10.1002/cncr.27761.
35. Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol. 2013;6:94. doi:10.1186/1756-8722-6-94.
36. Ding H, Ren H, Guo N, Huang X, Xu L, Zhang Y, et al. Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation. Beijing Da Xue Xue Bao. 2003;35(6):596-9.
37. Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D, et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002;99(4):1159-64.
38. Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, et al. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Biol Blood Marrow Transplant. 2015;21(6):1117-26. doi:10.1016/j.bbmt.2015.03.018.
39. Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, et al. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. Biol Blood Marrow Transplant. 2009;15(5):632-8. doi:10.1016/j.bbmt.2009.02.001.
40. Huang XJ, Chang YJ. Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(2):197-204. doi:10.1016/j.bbmt.2010.03.006.
41. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295-304.
42. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204-17.
43. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28(3):250-9.
44. Mahadeo KM, Masinsin B, Kapoor N, Shah AJ, Abdel-Azim H, Parkman R. Immunologic resolution of human chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(10):1508-15. doi:10.1016/j.bbmt.2014.06.030.
45. Bagriacik EU, Miller KS. Cell surface sialic acid and the regulation of immune cell interactions: the neuraminidase effect reconsidered. Glycobiology. 1999;9(3):267-75.
46. Marino JH, Hoffman M, Meyer M, Miller KS. Sialyltransferase mRNA abundances in B cells are strictly controlled, correlated with cognate lectin binding, and differentially responsive to immune signaling in vitro. Glycobiology. 2004;14(12):1265-74. doi:10.1093/glycob/cwh133.
47. Italiano Jr JE, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, et al. Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008;111(3):1227-33. doi:10.1182/blood-2007-09-113837.
48. van der Wal DE, Du VX, Lo KS, Rasmussen JT, Verhoef S, Akkerman JW. Platelet apoptosis by cold-induced glycoprotein Ibalpha clustering. J Thromb Haemostasis. 2010;8(11):2554-62. doi:10.1111/j.1538-7836.2010.04043.x.
49. Badlou BA, Spierenburg G, Ulrichts H, Deckmyn H, Smid WM, Akkerman JW. Role of glycoprotein Ibalpha in phagocytosis of platelets by macrophages. Transfusion. 2006;46(12):2090-9. doi:10.1111/j.1537-2995.2006.01034.x.
50. Badlou BA, Wu YP, Smid WM, Akkerman JW. Platelet binding and phagocytosis by macrophages. Transfusion. 2006;46(8):1432-43. doi:10.1111/j.1537-2995.2006.00913.x.
51. Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, et al. The clearance mechanism of chilled blood platelets. Cell. 2003;112(1):87-97.
52. Nash RA, Gooley T, Davis C, Appelbaum FR. The problem of thrombocytopenia after hematopoietic stem cell transplantation. Oncologist. 1996;1(6):371-80.
53. Bernstein SH, Nademanee AP, Vose JM, Tricot G, Fay JW, Negrin RS, et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood. 1998;91(9):3509-17.
54. Ji X, Zhang L, Peng J, Hou M. T cell immune abnormalities in immune thrombocytopenia. J Hematol Oncol. 2014;7(1):72. doi:10.1186/s13045-014-0072-6.
55. Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013;27(3):495-520. doi:10.1016/j.hoc.2013.03.001.
56. Chang YJ, Zhao XY, Huang XJ. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(4):440-9. doi:10.1016/j.bbmt.2013.11.028.
57. Xie M, Fu HX, Chang YJ, Xu LP, Liu DH, Zhang XH, et al. Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation. Int J Hematol. 2012;96(1):109-21. doi:10.1007/s12185-012-1099-5.
58. Yenicesu I, Yetgin S, Ozyurek E, Aslan D. Virus-associated immune thrombocytopenic purpura in childhood. Pediatr Hematol Oncol. 2002;19(6):433-7. doi:10.1080/08880010290097233.
59. Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus. 2014;23(6):554-67. doi:10.1177/0961203313499959.
60. Zhang YL, Zhou J, Wei XD, Jiang DX, Cheng AM, Hu JY, et al. Detection and screening for human cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients by different methods. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;15(3):558-62.
61. Elward K. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol Immunol. 2003;40(2-4):85-94. doi:10.1016/s0161-5890(03)00109-3.
62. Tribulatti MV, Mucci J, Van Rooijen N, Leguizamon MS, Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents. Infect Immun. 2005;73(1):201-7. doi:10.1128/IAI.73.1.201-207.2005.
63. Jansen AJ, Peng J, Zhao HG, Hou M, Ni H. Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia. Am J Hematol. 2015;90(5):E94-5. doi:10.1002/ajh.23953.
64. Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med. 2008;14(6):648-55. doi:10.1038/nm1760.
65. Wandall HH, Rumjantseva V, Sorensen AL, Patel-Hett S, Josefsson EC, Bennett EP, et al. The origin and function of platelet glycosyltransferases. Blood. 2012;120(3):626-35. doi:10.1182/blood-2012-02-409235.
66. Sorensen AL, Hoffmeister KM, Wandall HH. Glycans and glycosylation of platelets: current concepts and implications for transfusion. Curr Opin Hematol. 2008;15(6):606-11. doi:10.1097/MOH.0b013e328313e3bd.
67. Prajna K, Kumar JA, Rai S, Shetty SK, Rai T, Shrinidhi, et al. Predictive value of serum sialic acid in type-2 diabetes mellitus and its complication (nephropathy). J Clin Diagn Res. 2013;7(11):2435-7. doi:10.7860/JCDR/2013/6210.3567.
68. Miyagi T, Yamaguchi K. Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology. 2012;22(7):880-96. doi:10.1093/glycob/cws057.
69. Liang F, Seyrantepe V, Landry K, Ahmad R, Ahmad A, Stamatos NM, et al. Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments. J Biol Chem. 2006;281(37):27526-38. doi:10.1074/jbc.M605633200.
70. Shkandina T, Herrmann M, Bilyy R. Sweet kiss of dying cell: sialidase activity on apoptotic cell is able to act toward its neighbors. Autoimmunity. 2012;45(8):574-8. doi:10.3109/08916934.2012.719951.
71. Li S, Wang Z, Liao Y, Zhang W, Shi Q, Yan R, et al. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemostasis. 2010;8(2):341-50. doi:10.1111/j.1538-7836.2009.03653.x.
72. Leytin V. Apoptosis in the anucleate platelet. Blood Rev. 2012;26(2):51-63. doi:10.1016/j.blre.2011.10.002.
73. Masters SC, Fu H. 14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem. 2001;276(48):45193-200. doi:10.1074/jbc.M105971200.
74. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996;87(4):619-28.
75. Gilmour AM, Abdulkhalek S, Cheng TS, Alghamdi F, Jayanth P, O'Shea LK, et al. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer. Cell Signal. 2013;25(12):2587-603. doi:10.1016/j.cellsig.2013.08.008.
76. Hata K, Koseki K, Yamaguchi K, Moriya S, Suzuki Y, Yingsakmongkon S, et al. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents Chemother. 2008;52(10):3484-91. doi:10.1128/AAC.00344-08.
77. Qiu JH, Shao L, Zhou H, Wang X, Peng J, Hou M. Platelet desialylation is closely associated with cytotoxic T lymphocyte-mediated platelet destruction in immune thrombocytopenia. Blood. 2014;124(21):463.